Cryo-Cell International, Inc. (CCEL)

Cryo-Cell International Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 31, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019
Cash & Equivalents	0.2	0.41	1.7	8.26	10.36	6.54
Short-Term Investments	1.93	0.57	0.02	0.08	0.09	0.9
Trading Asset Securities	-	0.12	-	-	-	-
Cash & Short-Term Investments	2.13	1.1	1.72	8.34	10.45	7.45
Cash Growth	67.97%	-35.97%	-79.35%	-20.20%	40.36%	7.65%
Accounts Receivable	6.87	6.58	6.04	5.25	6.32	6.1
Receivables	6.87	6.58	6.04	5.25	6.32	6.1
Inventory	0.73	0.77	0.85	0.92	0.93	1.08
Prepaid Expenses	0.51	0.62	0.57	0.56	0.61	0.5
Other Current Assets	0.42	0.39	0.43	0.71	0.24	0.26
Total Current Assets	10.66	9.45	9.61	15.78	18.56	15.39
Property, Plant & Equipment	23.01	22.03	14.21	4.15	1.94	1.85
Long-Term Investments	-	0.31	0.31	0.31	0.31	0.31
Goodwill	1.94	1.94	1.94	1.94	1.94	1.94
Other Intangible Assets	0.94	0.99	15.15	16.21	1.53	1.25
Long-Term Deferred Tax Assets	20.49	20.49	13.74	12.01	10.36	9.08
Other Long-Term Assets	5.89	6.01	9.92	10.26	11.56	13.07
Total Assets	62.93	61.22	64.89	60.66	46.2	42.89
Accounts Payable	2	3.17	1.61	1.49	0.96	1.37
Accrued Expenses	2.68	3.74	3.24	3.06	1.94	1.91
Short-Term Debt	2.22	1.22	2.27	-	-	-
Current Portion of Long-Term Debt	0.17	0.17	0.15	1.9	3.1	3.1
Current Portion of Leases	0.38	0.23	0.3	0.31	0.28	-
Current Income Taxes Payable	-	1.43	0.34	-	0.96	0.18
Current Unearned Revenue	9.83	9.7	9.59	9.36	9.18	8.88
Other Current Liabilities	0.13	1.2	1.98	4.96	-	-
Total Current Liabilities	17.42	20.86	19.48	21.07	16.41	15.43
Long-Term Debt	8.33	8.43	8.58	-	2.84	5.86
Long-Term Leases	0.62	0.85	0.31	0.61	0.02	-
Long-Term Unearned Revenue	45.2	41.19	36	31.27	27.2	23.63
Other Long-Term Liabilities	0.92	0.92	2.04	3.52	2.38	4.92
Total Liabilities	72.49	72.25	66.41	56.48	48.87	49.84
Common Stock	0.15	0.15	0.15	0.15	0.14	0.14
Additional Paid-In Capital	44.04	43.41	42.6	41.59	36.58	35.92
Retained Earnings	-28.9	-31.16	-21.64	-16.74	-18.82	-22.44
Treasury Stock	-24.86	-23.43	-22.63	-20.81	-20.56	-20.56
Shareholders' Equity	-9.56	-11.03	-1.52	4.18	-2.67	-6.95
Total Liabilities & Equity	62.93	61.22	64.89	60.66	46.2	42.89
Total Debt	11.73	10.9	11.61	2.82	6.24	8.96
Net Cash (Debt)	-9.6	-9.79	-9.89	5.52	4.21	-1.51
Net Cash Growth	-	-	-	31.08%	-	-
Net Cash Per Share	-1.17	-1.17	-1.17	0.66	0.52	-0.18
Filing Date Shares Outstanding	8.06	8.29	8.44	8.5	7.57	7.55
Total Common Shares Outstanding	8.06	8.29	8.5	8.56	7.55	7.51
Working Capital	-6.76	-11.41	-9.87	-5.29	2.14	-0.04
Book Value Per Share	-1.19	-1.33	-0.18	0.49	-0.35	-0.93
Tangible Book Value	-12.44	-13.96	-18.62	-13.97	-6.14	-10.14
Tangible Book Value Per Share	-1.54	-1.68	-2.19	-1.63	-0.81	-1.35
Buildings	-	11.22	11.22	1.51	-	-
Machinery	-	8.75	7.74	6.84	6.63	6.57
Construction In Progress	-	6.71	-	-	-	-
Leasehold Improvements	-	1.26	1.26	1.21	1.2	1.2

Source: S&P Capital IQ. Standard template. Financial Sources.